Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19
1 other identifier
observational
230
1 country
3
Brief Summary
Severe COVID-19 patients at a high risk of venous thromboembolism. We studied patients in 2 intensive care units of university hospitals in Barcelona and Badalona, Spain. We performed a cut-off screening of deep venous thrombosis (DVT) with bilateral duplex ultrasound to 230 patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 2, 2020
CompletedFirst Posted
Study publicly available on registry
May 5, 2020
CompletedMay 6, 2020
May 1, 2020
24 days
May 2, 2020
May 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Venous thromboembolisms
Patients with symptomatic pulmonary embolism confirmed on the CT-angiography and those with a swollen limb and confirmed deep venous thrombosis on compression ultrasound were considered to have "symptomatic venous thromboembolisms". The remaining patients with positive limb ultrasound or CT-angiography were considered to have "asymptomatic venous thrombembolism"
7 days
Secondary Outcomes (1)
Deaths
7 days
Study Arms (1)
Venous thromboembolism
Patients at risk of venous thromboembolism (deep venous thrombosis and/or pulmonary embolism)
Interventions
All venous thromboembolisms suspected will diagnosed with ultrasound and CT-angiography
Eligibility Criteria
Patients with severe COVID-19 pneumonia admitted to the intensive care unit.
You may qualify if:
- Patients with severe COVID-19 pneumonia admitted to the intensive care unit
You may not qualify if:
- Treatment with Extracorporeal membrane oxygenation (ECMO)
- Pregnant or postpartum women
- Under 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Vall d´Hebron Research Institute VHIR
Barcelona, Catalonia, 08035, Spain
Hospital Germans Trias i Pujol. Universitat Autònoma de Barcelona
Badalona, 08916, Spain
Hospital Universitari Vall d'Hebron. Universitat Autonoma de Barcelona
Barcelona, 08035, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sergi Bellmunt, MD,PhD
Hospital Vall d'Hebron
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2020
First Posted
May 5, 2020
Study Start
April 1, 2020
Primary Completion
April 25, 2020
Study Completion
May 1, 2020
Last Updated
May 6, 2020
Record last verified: 2020-05